MedPath

Effects of Dietary Interventions on the Aging Brain

Phase 3
Conditions
Healthy
Interventions
Behavioral: Caloric restriction
Dietary Supplement: Omega-3 (fish oil capsules)
Dietary Supplement: Resveratrol
Dietary Supplement: Placebo
Registration Number
NCT00996229
Lead Sponsor
University Hospital Muenster
Brief Summary

The researchers will investigate whether caloric restriction or dietary supplementation could provide positive effects on general brain functions in healthy elderly people.

Detailed Description

The age-related degradation of cognitive functions even to the point of neurodegenerative disorders such as Alzheimer's disease are a growing public-health concern with devastating effects.

Referring to animal data, empirical studies, and pilot human trials, a healthy diet rich in unsaturated fatty acids and low in calories should improve cognitive functions such as learning and memory. To test this hypothesis, the researchers study general brain functions in healthy elderly subjects (50-80 years old) during a short term diet.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • healthy subjects
  • 50-80 years old
  • moderate to heavy weight (BMI 25-30)
  • must be able to change diet/take supplements at home
Exclusion Criteria
  • diabetes
  • younger than 50 years
  • BMI < 25
  • psychiatric medication
  • severe disease
  • MMSE < 26
  • eating disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Caloric restriction + placebo supplementationCaloric restriction-
Caloric restriction + placebo supplementationPlacebo-
Omega-3 supplementationOmega-3 (fish oil capsules)-
Placebo supplementationPlacebo-
Resveratrol supplementationResveratrol-
Primary Outcome Measures
NameTimeMethod
Auditory verbal Learning TaskBaseline (timepoint 0), after 6 months (timepoint 6 months)
Secondary Outcome Measures
NameTimeMethod
Functional/Structural brain changesBaseline (timepoint 0), after 6 months (timepoint 6 months)
Plasma biomarkersBaseline (timepoint 0), after 6 months (timepoint 6 months)f intervention

Trial Locations

Locations (1)

Department of Neurology, Charité Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath